• Overview
  • Eligibility
  • More info
  • Locations

Using 2h-glycosuria Combined With Fasting Plasma Glucose , Advanced Glycation End-product Alone or in Combination With Fasting Plasma Glucose in Diabetes Screening in Chinese Natural Population (NCT03025919)

Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population
Ages eligible for Study
12 Years to 70 Years
Genders eligible for Study
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Using the WHO criteria as the golden standard,drawing the ROC curve of 2h-UG combined with FPG, AGEsP alone or in combination with FPG,calculating the area under the ROC curve.

1 locations

China (1)
  • Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University
    recruiting
    Nanjing, Jiangsu, China
Status:
recruiting
Type:
Observational
Phase:
-
Start:
31 December, 2016
Updated:
02 May, 2017
Participants:
20000
Apply
A girl giving information about available additional trials.

FindMeCure helps you find, understand and join clinical trials from all over the world.

There are more clinical trials for your condition!